Mylan ships generic prostate drug

Pittsburgh-based drug maker launches generic version of Sanofi's Uroxatral

PITTSBURGH — Generic drug maker Mylan has begun shipping a drug for enlarged prostate, the company said Friday.

Mylan announced the launch of alfuzosin hydrochloride extended-release tablets in the 10-mg strength.

The drug is a generic version of Sanofi's Uroxatral, which had sales of about $241 million during the 12-month period ended in June, according to IMS Health.

Login or Register to post a comment.